Max Kugelman

460 total citations
25 papers, 341 citations indexed

About

Max Kugelman is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Max Kugelman has authored 25 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 14 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Max Kugelman's work include Carbohydrate Chemistry and Synthesis (6 papers), Chemical Synthesis and Analysis (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Max Kugelman is often cited by papers focused on Carbohydrate Chemistry and Synthesis (6 papers), Chemical Synthesis and Analysis (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Max Kugelman collaborates with scholars based in United Kingdom, United States and Russia. Max Kugelman's co-authors include Alan K. Mallams, Andrew W. Stamford, K. V. Bhaskara Rao, Robert S. Jaret, Doris P. Schumacher, Ingrid Mergelsberg, Koppaka V. Rao, Richard A. Wilson, David Cooper and Hans Reimann and has published in prestigious journals such as The Journal of Organic Chemistry, Phytochemistry and Journal of Pharmaceutical Sciences.

In The Last Decade

Max Kugelman

25 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Kugelman United Kingdom 10 183 178 62 36 25 25 341
Shoichiro Uyeo Japan 10 241 1.3× 102 0.6× 94 1.5× 14 0.4× 27 1.1× 38 339
Yoshikazu Wada Japan 12 176 1.0× 173 1.0× 105 1.7× 33 0.9× 17 0.7× 28 380
Roger J. Ponsford United States 11 279 1.5× 144 0.8× 171 2.8× 56 1.6× 58 2.3× 28 464
Jutta Kupka Germany 10 111 0.6× 163 0.9× 209 3.4× 62 1.7× 17 0.7× 10 395
Hermann Führer Switzerland 14 232 1.3× 207 1.2× 145 2.3× 25 0.7× 15 0.6× 29 430
Hideo Koshiyama United Kingdom 12 154 0.8× 212 1.2× 160 2.6× 37 1.0× 17 0.7× 16 363
TOMIZO NIWA United Kingdom 11 197 1.1× 212 1.2× 127 2.0× 50 1.4× 20 0.8× 14 387
L. L. HUCKSTEP United States 12 175 1.0× 174 1.0× 141 2.3× 27 0.8× 8 0.3× 19 368
J. A. Mabe United States 13 140 0.8× 300 1.7× 204 3.3× 93 2.6× 31 1.2× 25 534
Peter H. Milner United States 10 251 1.4× 160 0.9× 90 1.5× 31 0.9× 25 1.0× 26 435

Countries citing papers authored by Max Kugelman

Since Specialization
Citations

This map shows the geographic impact of Max Kugelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Kugelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Kugelman more than expected).

Fields of papers citing papers by Max Kugelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Kugelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Kugelman. The network helps show where Max Kugelman may publish in the future.

Co-authorship network of co-authors of Max Kugelman

This figure shows the co-authorship network connecting the top 25 collaborators of Max Kugelman. A scholar is included among the top collaborators of Max Kugelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Kugelman. Max Kugelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gloor, Gregory B., et al.. (2004). Preparation of Guanine PDE Inhibitors:  Development of the Common Synthetic Route Strategy. A Case Study. Organic Process Research & Development. 8(3). 396–400. 4 indexed citations
2.
Kugelman, Max, et al.. (2003). A novel synthesis of guanine PDE inhibitors via tricyclic imidazopyrimidines. Tetrahedron Letters. 44(13). 2721–2723. 9 indexed citations
3.
Puar, Mohindar S., et al.. (2000). Guanine hydrolysis under basic conditions to substituted imidazoles. Tetrahedron Letters. 41(26). 5025–5029. 3 indexed citations
4.
Kv, Rao, et al.. (1998). Diazomycins A, B, and C, three antitumor substances. I. Isolation and characterization.. PubMed. 7. 943–9. 4 indexed citations
5.
Wang, Yongfeng, Malcolm F. G. Stevens, Tze‐Ming Chan, et al.. (1997). Antitumor Imidazotetrazines. 35. New Synthetic Routes to the Antitumor Drug Temozolomide. The Journal of Organic Chemistry. 62(21). 7288–7294. 21 indexed citations
6.
Mergelsberg, Ingrid, et al.. (1997). ChemInform Abstract: Total Chiral Synthesis of Azole Antifungals via α‐Hydroxylation of Ketones.. ChemInform. 28(8). 3 indexed citations
7.
Kugelman, Max, et al.. (1997). A Practical Synthesis of “Metabolite A1” (AAMU) of Caffeine. Organic Process Research & Development. 1(1). 85–87. 5 indexed citations
8.
Mergelsberg, Ingrid, et al.. (1996). Total chiral synthesis of azole antifungals via α-hydroxylation of ketones. Tetrahedron Letters. 37(45). 8117–8120. 21 indexed citations
9.
Puar, Mohindar S., et al.. (1992). Decomposition of α‐Hydroxyaryl Ketones and Characterization of Some Unusual Products. Journal of Pharmaceutical Sciences. 81(12). 1199–1203. 6 indexed citations
10.
Davies, D. Huw, Max Kugelman, Paul Lee, et al.. (1981). Semisynthetic aminoglycoside antibacterials. Part 8. Synthesis of novel pentopyranosyl and pentofuranosyl derivatives of gentamine C1 and C1a. Journal of the Chemical Society Perkin Transactions 1. 2151–2151. 4 indexed citations
11.
Kugelman, Max, et al.. (1978). The structure of aminoglycoside antibiotic 66-40G produced by Micromonospora inyoensis.. The Journal of Antibiotics. 31(7). 643–645. 4 indexed citations
12.
Kugelman, Max, et al.. (1976). Indicine-N-oxide: the antitumor principle of Heliotropium indicum.. PubMed. 39(2-3). 125–8. 52 indexed citations
13.
Kugelman, Max, et al.. (1976). Semisynthetic aminoglycoside antibacterials. Part IV. Synthesis of antibiotic JI-20A, gentamicin B, and related compounds. Journal of the Chemical Society Perkin Transactions 1. 1126–1126. 3 indexed citations
14.
Kugelman, Max, Alan K. Mallams, David Crowe, et al.. (1976). Semisynthetic aminoglycoside antibacterials. Part II. Synthesis of gentamicin X2 and related compounds. Journal of the Chemical Society Perkin Transactions 1. 1097–1097. 6 indexed citations
15.
Kugelman, Max, et al.. (1976). Semisynthetic aminoglycoside antibacterials. Part I. Preparation of selectively protected garamine derivatives. Journal of the Chemical Society Perkin Transactions 1. 1088–1088. 5 indexed citations
16.
Reimann, Hans, David Cooper, Alan K. Mallams, et al.. (1974). Structure of sisomicin, a novel unsaturated aminocyclitol antibiotic from Micromonospora inyoensis. The Journal of Organic Chemistry. 39(11). 1451–1457. 50 indexed citations
17.
Kugelman, Max, et al.. (1973). THE PREPARATION OF GARAMINE, A NOVEL PSEUDODISACCHARIDE FROM SISOMICIN. The Journal of Antibiotics. 26(7). 394–395. 11 indexed citations
18.
Kugelman, Max, et al.. (1972). A crystalline saponin with anti-tumor activity from entada phaseoloides. Phytochemistry. 11(1). 171–173. 26 indexed citations
19.
Daniels, P., et al.. (1971). Mass spectral studies on aminocyclitol antibiotics. Journal of the Chemical Society D Chemical Communications. 1629–1629. 20 indexed citations
20.
Kugelman, Max, et al.. (1963). BA-17039-A AND -B: NEW CYTOTOXIC AND ANTIBIOTIC SUBSTANCES.. PubMed. 161. 73–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoichiro Uyeo Breakdown of academic impact, for papers by Yoshikazu Wada Breakdown of academic impact, for papers by Roger J. Ponsford Breakdown of academic impact, for papers by Jutta Kupka Breakdown of academic impact, for papers by Hermann Führer Breakdown of academic impact, for papers by Hideo Koshiyama Breakdown of academic impact, for papers by TOMIZO NIWA Breakdown of academic impact, for papers by L. L. HUCKSTEP Breakdown of academic impact, for papers by J. A. Mabe Breakdown of academic impact, for papers by Peter H. Milner
Rankless by CCL
2026